EACVI President

11/ Until then, I wish you all some well-deserved downtime, a joyful festive season, and happy holidays. Thank you for being part of the #EACVI family. @VDelgadoGarcia

🏃‍♀️❤️ New ESC Clinical Consensus Statement on Cardiovascular Imaging in Athletes Excited to see the publication of this comprehensive two-part Clinical Consensus Statement from the European Association of Preventive Cardiology (EAPC) and the European Association of Cardiovascular Imaging (EACVI). These documents provide practical guidance on the indications, protocols, and interpretation of cardiovascular imaging for the evaluation and management of athletes—helping clinicians distinguish physiological cardiac adaptation from underlying cardiovascular disease and supporting informed return-to-play decisions. 📘 Part 1 focuses on exercise imaging, outlining when and how exercise stress imaging should be used to assess cardiovascular performance, uncover exercise-induced abnormalities, and guide clinical decision-making in athletes. academic.oup.com/eurjpc/advance… 📘 Part 2 covers Cardiovascular Magnetic Resonance (CMR), Cardiac CT, and Nuclear Imaging, offering practical recommendations for selecting the appropriate modality, standardized imaging protocols, and interpreting findings in the context of athletic cardiac remodeling versus pathology. academic.oup.com/ehjcimaging/ad… This consensus represents an important step toward harmonizing cardiovascular imaging practices in sports cardiology and will be a valuable resource for cardiologists, sports physicians, radiologists, and everyone involved in the cardiovascular care of athletes. Congratulations to all the authors and contributors on this outstanding collaborative effort! #SportsCardiology #CardiovascularImaging #AthleteHeart #EAPC #EACVI #ESC #Cardiology #CMR #CardiacCT #Echocardiography #NuclearCardiology #SportsMedicine

Building a large cardiovascular imaging database? 🫀📊 In this #EACVI How-to episode, Steffen Petersen and Sonia Borodzicz-Jazdyk share practical tips and tricks on building and managing large cardiovascular imaging databases for research. 🎥 Watch: esc365.escardio.org/event/2204 @rafavidalperez @YBououdina @MSBBrandao @ydaryani @Elizabeth_antos @pfelissamburu @CharlesFauvel @alexsfelixecho @galzeranod @andgiannopmd @hrt01a @WilliamKokFaiK1 @M_Marwan_ @drahmedmohsen85 @aniela_petrescu @benayozbay @slumberbell @senguptasp @ElizabetaK10533 @samsrivastava77 @MihaiTrofenciuc @C_VanDeHeyning @drozgeozden @Giulia_Vinco @VazyurVasquez #ESC365 #CardiovascularImaging #Cardiology #Research

Two inspiring days at the #EACVI HIT Summer School on #Cardiomyopathies in Graz! A huge thank you to Klemens Ablasser for hosting this outstanding event with #EACVIHIT Chair @DrGEMandoli and Deputy Chair @eromerodorta and to our outstanding faculty: Gregor Heitzinger, Nuno Cardim, Nicolas Verheyen, Nora Schwegel, Martin Grübler, Sonia Borodzicz-Jazdzyk, Tomaz Podlesnikar, Vlatka Reskovi Luksic, and Johannes Gollmer. Thank you to all participants for making it such a success. We look forward to welcoming you to future EACVI educational events! @U_Rohrer @nicoverheyen1 @BinderRodriguez @SBorodzicz @TomazP3 @MeduniGraz @Sarah_Moharem @denisamuraru @s_e_petersen @VictoriaDe32503 #CardiovascularImaging #Echocardiography #MedEd

🫀 New research highlights the value of dual-chamber strain phenotyping in HFpEF #HFpEF is a heterogeneous condition, making risk stratification challenging. This new study published @EHJCVIEiC demonstrates that combining left ventricular global longitudinal strain with left atrial reservoir strain can identify distinct phenotypic groups associated with different clinical outcomes. The findings suggest that integrating ventricular and atrial strain assessment may improve prognostic evaluation beyond conventional measures, helping clinicians better identify patients at higher risk. As echocardiographic strain imaging becomes increasingly accessible, dual-chamber assessment may play an important role in advancing precision medicine for patients with #HFpEF. Read the study here: academic.oup.com/ehjcimaging/ad… @rafavidalperez @YBououdina @MSBBrandao @ydaryani @Elizabeth_antos @pfelissamburu @CharlesFauvel @alexsfelixecho @galzeranod @andgiannopmd @hrt01a @WilliamKokFaiK1 @M_Marwan_ @drahmedmohsen85 @aniela_petrescu @benayozbay @slumberbell @senguptasp @ElizabetaK10533 @samsrivastava77 @MihaiTrofenciuc @C_VanDeHeyning @drozgeozden @Giulia_Vinco @VazyurVasquez @VictoriaDe32503 #HFpEF #Echocardiography #CardiacImaging #Cardiology #StrainImaging #HeartFailure #PrecisionMedicine #EchoFirst

#ArtificialIntelligence and the evolution of the electrocardiogram: from cardiovascular diagnostic tool to digital biomarker ow.ly/AZXX50ZjUAE #EHJDigital #Review @BruiningNico @rafavidalperez @fwasselbergs @rbcasado

⚡ New research highlights the central role of cardiac energetics across cardiovascular disease. A comprehensive meta-analysis published in the European Heart Journal – Imaging Methods and Practice pooled data from 176 studies involving 7,843 cardiac phosphorus MR spectroscopy examinations to establish reference values for myocardial phosphocreatine-to-ATP (PCr/ATP) ratios across health and disease. Key findings: 🔹 Healthy individuals demonstrated a pooled PCr/ATP ratio of 1.96 🔹 Patients with heart failure with reduced ejection fraction showed a 21% reduction 🔹 Those with heart failure with preserved ejection fraction had an 18% reduction 🔹 Additional reductions were observed across multiple cardiovascular conditions, including valvular heart disease and diabetes. These findings reinforce impaired myocardial energetics as a common pathway across diverse cardiac diseases and provide valuable reference data for future research and clinical applications using ³¹P magnetic resonance spectroscopy. Read the full paper here: academic.oup.com/ehjimp/advance… #Cardiology #CardiacImaging #HeartFailure @EHJIMPEiC @VictoriaDe32503 @HeartDocSharon @rafavidalperez @Hragy @hvanspall @echo_stepbystep @AnnaKateBarton @KemalogluOz @saramoscatelli7 @Sarah_Moharem @denisamuraru @s_e_petersen

🫀✨ TR Imaging in Real Life: Are We There Yet? A new EACVI international survey 🌍 (530 clinicians, 69 countries!) reveals how we actually assess tricuspid regurgitation (TR) in daily practice 👇 🔍 Key takeaways: 🥇 2D Echo (TTE) still dominates (≈96%) 📉 Advanced tools (3D, CMR, CT) = underused ⚠️ Quantitative parameters (EROA, regurgitant volume) → used in <50% 🧠 RV strain & advanced metrics limited by time + software access 🌐 Huge heterogeneity across centres 💡 Clinical message: We’re moving forward… but slowly ⏳ 👉 Need for better access, training & standardization 👉 Multimodality imaging should become the new normal 🚨 TR is no longer “the forgotten valve” 📄 Read the full paper: 👉 🔗 DOI: 10.1093/ehjimp/qyag008 #Cardiology #EACVI #Echocardiography #TR #ValvularHeartDisease #CMR #CardiacCT #MedEd #CardioTwitter #Imaging 🩺📊

🎧 “Heartbeat of Diagnosis” – OST Summary ❤️‍🔥🩺 In a world where chest pain raises suspicion… two rivals face off ⚔️ 🔬 Biomarkers + 🎧 Phonocardiography 🆚 📊 ESC 2024 Risk Model Who wins? 🤔 ✨ Key vibes from the study: 🎯 CADScor system = high sensitivity (93.8%) & strong rule-out power 🛡️ Negative predictive value ≈ 90% → great to exclude CAD 📊 Comparable performance vs ESC model (AUC ~0.74 vs 0.72) ➕ Adding hs-Troponin? → only small improvement ⚖️ Final take: 👉 ESC model = solid baseline 👉 CADScor = 🔥 excellent complementary tool 💡 Clinical plot twist: Not a replacement… but a team-up strategy 🤝 🎶 Chorus: “Listen to the heart… before you scan it” ❤️👂 🔗 Read the full paper here: 👉doi.org/10.1093/ehjimp… #Cardiology #CAD #ESCguidelines #MedTech #Phonocardiography #Biomarkers #ClinicalResearch #HeartHealth #AIinMedicine #Diagnostics 🚀

🫀 Ready to sharpen your #HCM imaging skills? Join the #EACVI HCM Masterclass 2026 in Lisbon for expert-led sessions, multimodality imaging updates and interactive case discussions. 📅 24 Sept 2026 📍 Lisbon, Portugal Register now👇 esc365.escardio.org/event/2688 @rafavidalperez @YBououdina @MSBBrandao @ydaryani @Elizabeth_antos @pfelissamburu @CharlesFauvel @alexsfelixecho @galzeranod @andgiannopmd @hrt01a @WilliamKokFaiK1 @M_Marwan_ @drahmedmohsen85 @aniela_petrescu @benayozbay @slumberbell @senguptasp @ElizabetaK10533 @samsrivastava77 @MihaiTrofenciuc @C_VanDeHeyning @drozgeozden @Giulia_Vinco @VazyurVasquez

Are you attending ASE 2026? Come and meet me on the EACVI booth no.510 #EACVI #escardio #echofirst #ase2026 @ASE360 @denisamuraru @EACVIPresident

What a fantastic #CardioOncology2026 meeting in Vienna! 🇦🇹 As President of EACVI, I would like to warmly congratulate the @ESCardioOnco Council and its Scientific Congress Committee for assembling an outstanding and genuinely multidisciplinary faculty and audience. Together, we are learning from emerging evidence, striving to answer the remaining unknowns, and fostering collaborations that will shape the future of cardio-oncology. Meetings like these demonstrate the power of bringing diverse expertise together to improve cardiovascular care for patients with cancer worldwide. #EACVI #CardioOncology2026 #CardioOncology @ESCardioOnco @ESCAdvocacy @slumberbell @chiarabd @NAjmoneMarsan @gpontone1 @Ph_Bertrand @Cosyns @charles_driving @rafavidalperez @rmanka_ @Sarah_Moharem @denisamuraru @ImagenCardiaca @s_e_petersen @VictoriaDe32503

#EHJCVI🫀Keep the foCUS on poCUS in emergency and critical care settings:💡improve outcomes. AI will enhance diagnostic accuracy 🚨Ongoing practice and continuous learning are essential to maintain competence 👉 doi.org/10.1093/ehjci/… #poCUS #ESC #echofirst

🎙️ EACVI CardioTalk Ep032 | Advances in Cardiovascular Imaging When does flow matter in cardiovascular imaging? Join Dr Alexander Gall and Prof @HEARTinMagnet as they discuss Clinical Insights from 4D Flow CMR and explore the evolving role of cardiovascular magnetic resonance in mitral valve disease. 🫀 In this episode, they review key findings from their recent article published in the European Heart Journal and discuss how 4D Flow CMR can enhance our understanding and assessment of valvular heart disease. 📖 Read the article: doi.org/10.1093/eurhea… 🎧 Listen to the podcast: esc365.escardio.org/event/2592 @rafavidalperez @YBououdina @MSBBrandao @ydaryani @Elizabeth_antos @pfelissamburu @CharlesFauvel @alexsfelixecho @galzeranod @andgiannopmd @hrt01a @WilliamKokFaiK1 @M_Marwan_ @drahmedmohsen85 @aniela_petrescu @benayozbay @slumberbell @senguptasp @ElizabetaK10533 @samsrivastava77 @MihaiTrofenciuc @C_VanDeHeyning @drozgeozden @Giulia_Vinco @VazyurVasquez #EACVI #CardioTalk #CMR #4DFlowCMR #CardiovascularImaging #MitralValveDisease #EHJ #Cardiology #MedEd

🫀 New Study: Cardiac Remodeling and Clinical Outcomes After Mitral Edge-to-Edge Repair With the PASCAL® System In this study of 130 patients with severe symptomatic mitral regurgitation undergoing transcatheter edge-to-edge repair (TEER) with the PASCAL® system: 🔹 Cardiac index improved by 11.4% immediately after the procedure 🔹 Left atrial pressures decreased by 37% 🔹 Left ventricular size was reduced at follow-up, indicating reverse cardiac remodeling 🔹 Right ventricular function significantly improved 🔹 Patients with improved left ventricular global longitudinal strain (GLS) experienced lower rates of heart failure hospitalization and mortality 📌 The findings suggest that the acute haemodynamic improvements achieved during PASCAL TEER may translate into favourable cardiac remodeling and improved mid-term clinical outcomes. Early post-procedural haemodynamic assessment could help identify patients most likely to benefit from the intervention. 🔗 Read the study: academic.oup.com/ehjimp/advance… #Cardiology #StructuralHeart #MitralRegurgitation #TEER #PASCAL #HeartFailure #CardiacImaging #Echocardiography #InterventionalCardiology #MedTwitter

🫀 New ESC Cardio-Oncology Working Group & EACVI Clinical Consensus Statement: Cardiovascular Imaging for Coronary and Peripheral Artery Disease in Patients with Cancer As cancer survival continues to improve, cardiovascular disease has emerged as a major determinant of long-term outcomes in patients with cancer and survivors. Both cancer itself and cancer therapies can accelerate the development of coronary artery disease (CAD) and peripheral artery disease (PAD). 🔍 Key messages from this consensus statement: ✅ Cardiovascular imaging is essential for baseline cardiovascular risk assessment before, during, and after cancer treatment. ✅ CAD and PAD are increasingly recognized complications in oncology patients and require early detection, risk stratification, and monitoring. ✅ While imaging indications are generally similar to those in the non-cancer population, imaging strategies often need to be individualized due to the unique pathophysiology and clinical presentations associated with cancer and its treatments. ✅ Multimodality imaging—including echocardiography, cardiac CT, CMR, nuclear imaging, and vascular imaging—plays a central role in diagnosis, treatment planning, and longitudinal follow-up. ✅ The document provides practical guidance to support clinicians in selecting the most appropriate imaging modality across the cancer continuum. 📌 This consensus highlights the importance of close collaboration between cardiologists, oncologists, vascular specialists, and imaging experts to optimize cardiovascular outcomes for patients with cancer. 🔗 Read the full document: academic.oup.com/ehjcimaging/ad… #CardioOncology #ESC #EACVI #CardiacImaging #CancerSurvivorship #CoronaryArteryDisease #PeripheralArteryDisease #Cardiology #Oncology #Echocardiography #CardiacCT #CMR #CardioTwitter #MedTwitter

📌Transseptal puncture in cardiovascular interventions: a clinical consensus statement of the European Heart Rhythm Association, the Heart Failure Association, the European Association of Percutaneous Cardiovascular Interventions, the European Association of Cardiovascular Imaging of the ESC, and the Association for European Paediatric and Congenital Cardiology 👉ow.ly/tG3450Z9cPt @EuropaceEiC @GiulioConteMD @Dominik_Linz @FraSantoroMD @AndyZhangMD @marcovitoloMD @DavideMei93 #Europace #arrhyhtmias

#EHJCVI 🫀 Sex differences in alloHSCT outcomes: same MACE, but rLVEF independent predictor of early MACE ONLY in females. ♀️HF & pericardial disease ♂️HF & SVT ⏳TIME for sex-specific risk stratification. Read more 👉 doi.org/10.1093/ehjci/… #CardioOncology

🎬 New EACVI HIT Bite just dropped! “Tips & Tricks to Correctly Quantify Tricuspid Regurgitation by TTE” 🎙️ Presented by Dr @CharlesFauvel Quantifying TR by transthoracic echocardiography remains one of the most challenging tasks in valve imaging — and Dr. Fauvel breaks it down in a concise, practical video you’ll want to bookmark. 🔑 Perfect timing ahead of tomorrow’s EACVI Webinar on TR: From Diagnosis to Transcatheter Treatment in light of the 2025 ESC Guidelines 📅 June 10th 👥 Faculty: 🎤 Host: Prof. Francesco Maisano — IRCCS San Raffaele Scientific Institute, Italy 🎤 Speaker: Dr. Covadonga Fernandez-Golfin — Ramon y Cajal University Hospital, Spain 🎤 Speaker: Assoc. Prof. @denisamuraru — University of Milan Bicocca, Italy 👉 Watch the HIT Bite here 📝 Register for the webinar: esc365.escardio.org/event/2258 @DrGEMandoli @Giulia_Vinco @rafavidalperez @YBououdina @MSBBrandao @ydaryani @Elizabeth_antos @pfelissamburu @CharlesFauvel @alexsfelixecho @galzeranod @andgiannopmd @hrt01a @WilliamKokFaiK1 @M_Marwan_ @drahmedmohsen85 @aniela_petrescu @benayozbay @slumberbell @senguptasp @ElizabetaK10533 @samsrivastava77 @MihaiTrofenciuc @C_VanDeHeyning @drozgeozden @VazyurVasquez @Sarah_Moharem @VictoriaDe32503